Filter Results:
(172)
Show Results For
- All HBS Web
(172)
- News (51)
- Research (89)
- Events (2)
- Multimedia (3)
- Faculty Publications (47)
Show Results For
- All HBS Web
(172)
- News (51)
- Research (89)
- Events (2)
- Multimedia (3)
- Faculty Publications (47)
- 26 Apr 2011
- News
BioMine Strikes Gold
U.S. Sahil Patel, MBA '05 PhytoTEK biologic infection solutions Watch their pitch. Northwestern U.S. Privahini Bradoo, MBA '08 BioMine e-waste mining solutions Watch their pitch. Southwestern U.S. Ali Fakhari, MBA '07 WikiPay mobile... View Details
- 01 Mar 2019
- News
The Blue-Green Revolution
the single-celled organisms to bulk up on fat like bears preparing for winter. Alas, just like bears, the microscopic butterballs eventually go into hibernation. And once that happens, they stop growing, negating the gains made in oil production. SGI solved that View Details
- 31 Oct 2023
- Blog Post
Climate Change Pioneers in the Class of 1978
faculty chair of the HBS Business and Environment Initiative, Grace Chao (Section A) organized the panel. Our three alumni discussed their pioneering activities: Steve Kahn (Section A) is the co-founder and executive chairman of NewLeaf Symbiotics, an agricultural... View Details
- Web
2.3 Community Standards of Conduct | MBA
misconduct; harassment, coercion or other conduct that threatens the health or safety of any person; threats involving deadly weapons, explosives, bombs, chemical or biological agents, or other deadly devices; theft, misappropriation, or... View Details
- 14 Apr 2014
- News
The Puzzle of Life
capitalize companies that may not make sense for venture funds but do make sense for smart angels who have more patience than most VCs." Among those companies: Rani Therapeutics, an early-stage venture focused on making injectable View Details
- 06 Jun 2017
- First Look
First Look at New Research and Ideas: June 6, 2017
Pharmacyclics is a biotechnology company that had received FDA approval in late 2013 for its flagship asset Imbrivica (ibrutinib), a biologic treatment for chronic lymphocytic leukemia and two other even rarer blood malignancies. Entering... View Details
Keywords: Sean Silverthorne
- 09 Aug 2016
- First Look
August 9, 2016
drugs that have been shown to be therapeutically equivalent to an already approved original biologic drug—have only been approved in the United States since 2015. Europe has had biosimilar entry since 2006. This paper considers how... View Details
Keywords: Sean Silverthorne
- 27 Apr 2023
- News
Life Preserver
transplant organs from a few hours to a few days or possibly longer. "Eventually, we want to stop biological time," says Giwa, who is CEO of Sylvatica. (He left Ossium in 2018 but also is the cofounder and chairman of Elevian, a biotech... View Details
Keywords: April White
- 18 Jul 2024
- Blog Post
Harvard Business School Announces Its 2024-2025 Blavatnik Fellows
startup aiming to make biologics more accessible to patients worldwide. Sanso was created to commercialize the microporous water technology out of Jarad Mason's lab at Harvard, a novel solution to dramatically increase the oxygen capacity... View Details
- 28 Feb 2011
- News
Rebooting the Human Condition
engineered cells, biological tissue, and robots. This perfect storm of innovation will allow humans to shape their own evolution (as well as that of other species) and create solutions to energy, health, and economic problems. Enriquez... View Details
- 01 Dec 2019
- News
In My Humble Opinion: Taking Attendance
people to think about what they would want for their own biological child,” she says. “Ninety-eight percent of our students are minorities, eighty-nine percent qualify for free or reduced lunch, and eighty-four percent will be... View Details
- 01 Feb 2000
- News
The Future Is Now: 21st-Century Business Pondered at HBS Forum
there will be entities that claim they are human because they will be copies of human thinking." As humans, he said, "we will put devices in our own brains to expand our own thinking so there will be a real merger of biological and... View Details
- 10 Oct 2017
- First Look
First Look at New Research and Ideas, October 10, 2017
Sigman Abstract—We study desensitization to crime in a lab experiment by showing footage of criminal acts to a group of subjects, some of whom have been previously victimized. We measure biological markers of stress and behavioral indices... View Details
Keywords: Sean Silverthorne
- 31 May 2011
- First Look
First Look: May 31
confident of the market potential for mobile payments, they recognized the challenges they faced in scaling their current business model. Purchase this case:http://cb.hbsp.harvard.edu/cb/product/811029-PDF-ENG Office of Technology Transfer—Shanghai Institutes for View Details
Keywords: Sean Silverthorne
- 01 May 2007
- First Look
First Look: May 1, 2007
(along with personal relations), laws and regulations can evolve to facilitate real estate investments. Purchase this case: http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=207090 The Convention on Biological Diversity:... View Details
Keywords: Sean Silverthorne
- 06 Dec 2018
- News
Source Code
surroundings, and learning as we go. That’s biological intelligence. But artificial intelligence—at least the way that it’s currently constructed—doesn’t work this way. Let’s use Google as an example. HEAR MORE Listen to Donna Dubinsky... View Details
- Web
Finalists | New Venture Competition
2024) Daniel Erdosy We help drug manufacturers produce life-saving biologics more efficiently, in order to deliver cheaper drugs to patients worldwide. SaveSpace Katharina Kelm (MBA 2024) Kelvin Kassis Vanessa Brodt Jeremy Mallahn We help... View Details
- 01 Aug 2001
- News
Cleveland Global Alumni Conference a Sold-Out Success
& Co., kicked off the first plenary session with a quick overview of factors contributing to the U.S. pharmaceutical industry's success in competing in the global market. Among other ad- vantages, Gilmartin cited the U.S. government's investment in View Details
- 15 Sep 2020
- Blog Post
One Month into the New MS/MBA Biotech
Alberts et al. Thus, to answer your question, it’s possible that a non-science major may be prepared if they have the necessary course background in molecular and cellular biology, whereby a student who majored in a biological science... View Details
- 11 Sep 2007
- First Look
First Look: September 11, 2007
developing proven molecules from strategic partners to leapfrog competition and create large molecule biologics in India. The company understood that its transition from an API to an innovation-led company focused on new View Details
Keywords: Martha Lagace